These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37310401)

  • 21. Prognostic risk assessment model and drug sensitivity analysis of colon adenocarcinoma (COAD) based on immune-related lncRNA pairs.
    Hao Z; Liang P; He C; Sha S; Yang Z; Liu Y; Shi J; Zhu Z; Chang Q
    BMC Bioinformatics; 2022 Oct; 23(1):435. PubMed ID: 36258178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Novel Pyroptosis-Related Gene Signature for Predicting the Prognosis and the Associated Immune Infiltration in Colon Adenocarcinoma.
    Chen Z; Han Z; Nan H; Fan J; Zhan J; Zhang Y; Zhu H; Cao Y; Shen X; Xue X; Lin K
    Front Oncol; 2022; 12():904464. PubMed ID: 35912258
    [TBL] [Abstract][Full Text] [Related]  

  • 23. KRAS codon 12 and 13 mutations in relation to disease-free survival in BRAF-wild-type stage III colon cancers from an adjuvant chemotherapy trial (N0147 alliance).
    Yoon HH; Tougeron D; Shi Q; Alberts SR; Mahoney MR; Nelson GD; Nair SG; Thibodeau SN; Goldberg RM; Sargent DJ; Sinicrope FA;
    Clin Cancer Res; 2014 Jun; 20(11):3033-43. PubMed ID: 24687927
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Establishing and Validating an Aging-Related Prognostic Four-Gene Signature in Colon Adenocarcinoma.
    Zheng L; Yang Y; Cui X
    Biomed Res Int; 2021; 2021():4682589. PubMed ID: 34790819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of sixteen metabolic genes as potential biomarkers for colon adenocarcinoma.
    Zhao F; Liu Y; Gu X; Zhang B; Song C; Cui B
    J BUON; 2021; 26(4):1252-1259. PubMed ID: 34564978
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of a prognostic model for mitophagy-related genes in colon adenocarcinoma: A study based on TCGA and GEO databases.
    Tang Y; Guo H; Chen L; Wang X; Chen Q; Gou L; Liu X; Wang X
    PLoS One; 2023; 18(4):e0284089. PubMed ID: 37023088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Based on cuproptosis-related lncRNAs, a novel prognostic signature for colon adenocarcinoma prognosis, immunotherapy, and chemotherapy response.
    Li C; Zhang K; Gong Y; Wu Q; Zhang Y; Dong Y; Li D; Wang Z
    Front Pharmacol; 2023; 14():1200054. PubMed ID: 37377924
    [No Abstract]   [Full Text] [Related]  

  • 28. Comprehensive Analysis Identifies PI3K/Akt Pathway Alternations as an Immune-Related Prognostic Biomarker in Colon Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitor Treatment.
    Lin A; Gu T; Hu X; Zhang J; Luo P
    J Immunol Res; 2022; 2022():8179799. PubMed ID: 35707003
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development and validation of a ferroptosis-related lncRNAs prognosis signature in colon cancer.
    Cai HJ; Zhuang ZC; Wu Y; Zhang YY; Liu X; Zhuang JF; Yang YF; Gao Y; Chen B; Guan GX
    Bosn J Basic Med Sci; 2021 Oct; 21(5):569-576. PubMed ID: 33714257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel prognostic model for patients with colon adenocarcinoma.
    Yin C; Wang W; Cao W; Chen Y; Sun X; He K
    Front Endocrinol (Lausanne); 2023; 14():1133554. PubMed ID: 36923226
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development and validation of a metabolic gene signature for predicting overall survival in patients with colon cancer.
    Ren J; Feng J; Song W; Wang C; Ge Y; Fu T
    Clin Exp Med; 2020 Nov; 20(4):535-544. PubMed ID: 32772211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of Interleukin-1 Signaling Alterations of Colon Adenocarcinoma Identified Implications for Immunotherapy.
    Zhou X; Liu Y; Xiang J; Wang Y; Wang Q; Xia J; Chen Y; Bai Y
    Front Immunol; 2021; 12():665002. PubMed ID: 34367132
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An epithelial-mesenchymal transition-related mRNA signature associated with the prognosis, immune infiltration and therapeutic response of colon adenocarcinoma.
    Zhang Y; Li Y; Zuo Z; Li T; An Y; Zhang W
    Pathol Oncol Res; 2023; 29():1611016. PubMed ID: 36910014
    [No Abstract]   [Full Text] [Related]  

  • 34. Exploration of the relationship between tumor mutation burden and immune infiltrates in colon adenocarcinoma.
    Ouyang R; Li Z; Peng P; Zhang J; Liu J; Qin M; Huang J
    Int J Med Sci; 2021; 18(3):685-694. PubMed ID: 33437203
    [No Abstract]   [Full Text] [Related]  

  • 35. System analysis based on the ER stress-related genes identifies WFS1 as a novel therapy target for colon cancer.
    Yang X; Zhang C; Yan C; Ma L; Ma J; Meng X
    Aging (Albany NY); 2022 Nov; 14(22):9243-9263. PubMed ID: 36445321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment and validation of a prognostic model based on HRR-related lncRNAs in colon adenocarcinoma.
    Tang X; Lin Y; He J; Luo X; Liang J; Zhu X; Li T
    World J Surg Oncol; 2022 Mar; 20(1):74. PubMed ID: 35264195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comprehensive analysis of the prognosis, tumor microenvironment, and immunotherapy response of SDHs in colon adenocarcinoma.
    Nan H; Guo P; Fan J; Zeng W; Hu C; Zheng C; Pan B; Cao Y; Ge Y; Xue X; Li W; Lin K
    Front Immunol; 2023; 14():1093974. PubMed ID: 36949947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ferroptosis-Related Long Noncoding RNAs as Prognostic Marker for Colon Adenocarcinoma.
    Qiu Y; Li H; Zhang Q; Qiao X; Wu J
    Appl Bionics Biomech; 2022; 2022():5220368. PubMed ID: 35432591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic Value of BRAF and KRAS Mutations in MSI and MSS Stage III Colon Cancer.
    Taieb J; Le Malicot K; Shi Q; Penault-Llorca F; Bouché O; Tabernero J; Mini E; Goldberg RM; Folprecht G; Luc Van Laethem J; Sargent DJ; Alberts SR; Emile JF; Laurent Puig P; Sinicrope FA
    J Natl Cancer Inst; 2017 May; 109(5):. PubMed ID: 28040692
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome‑scale analysis to identify potential prognostic microRNA biomarkers for predicting overall survival in patients with colon adenocarcinoma.
    Wei HT; Guo EN; Liao XW; Chen LS; Wang JL; Ni M; Liang C
    Oncol Rep; 2018 Oct; 40(4):1947-1958. PubMed ID: 30066920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.